Method of treating lower urinary tract disorders

The invention relates to a method of treating at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom ...

Landau, Steven B，Miller, Cheryl L，Fraser, Matthew O - US

Statin pharmaceutical compositions and related methods of treatment

The invention provides novel omega-3 oil solutions of one or more statins. These solutions are readily bioavailable. Notably, because the solutions of the invention contain an omega-3 oil as the major ingredient, they not only provide an...

H Guzman，J Remenar，O Almarsson - US

DESIGN AND EVALUATION OF NOVEL BI-LAYERED TABLET FOR THE EFFECTIVE TREATMENT OF HYPERTENSION

The drugs today are being synthesised by a variety of modern chemical techniques. The new chemical entities thus designed have a variety of issues which hamper their translation to actual market. These issues are low aqueous solubility, ...

R Ghadi，H Garse，N Dand，... - 《Indo American Journal of Pharmaceutical Research》

storage stable drug contains pravastatin calcium and an omega-3 oil, wherein the omega-3 oil comprises 46% ethyl ester of eicosapentaenoic acid, 38% ethyl ...

The invention provides novel omega-3 oil solutions of one or more statins. These solutions are readily bioavailable. Notably, because the solutions of the ...

H Guzman，J Remenar，O Almarsson - US

STABLE PHARMACEUTICAL COMPOSITIONS, PREFERABLY TABLETS, OF HMG-COA REDUCTASE INHIBITOR AND PROCESS FOR PREPARATION THEREOF

The present invention relates to stable pharmaceutical compositions (preferably a tablet) of HMG-CoA reductase inhibitor and process for preparation thereof. More particularly, it relates to pharmaceutical compositions of HMG-CoA reducta...

DIXIT, MONESH, PRAMOD，NAVALE, SURYAKANT, VAMANRAO，VAYA, NAVIN, ISHWARLAL - WO

Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators

提供了一种用α Provides a with α

MO Fraser，KB Thor，EC Burgard，... - WO

STABILIZED PHARMACEUTICAL COMPOSITIONS OF PREFERABLY A STATIN

Stabilized pharmaceutical composition comprising a therapeutically effective amount of one or more active pharmaceutical ingredients capable of degradation in a low pH environment and a stabilizing effective amount of one or more amino-g...

SRINIVAS ARRA GANGA，SAPRE BEENA AMOL，CHACHARE YOGESH ANANDA，... - WO

Stable pharmaceutical compositions comprising a HMG-CoA reductase inhibitor

Oral, storage-stable pharmaceutical composition (A) that contains specific inhibitors (Ia) and (Ib) of hydroxymethyl-glutarate co-enzyme A reductase (HMG-CoA) and at least one non-alkaline pharmaceutical auxiliary. Oral, storage-stable p...

R Jessica，RT Dr.，S Christof. - EP

Multiple dosage forms comprising fenofibrate or fenofibric acid in combination with hmg co a reductase inhibitors such as statins

The present invention relates to pharmaceutical formulations comprising a HMG-CoA reductase enzyme inhibitor and a fibric acid derivative in order to be used in the treatment of hyperlipoproteinemia, hypertriglyceridemia, hypercholestero...

M Bilgic - WO

Stable controlled release pharmaceutical compositions containing pravastatin

Stabilized sustained release pharmaceutical preparations containing a drug which is sensitive to a low pH environment, such as pravastatin are disclosed in which pravastatin degradation is prevented with a buffering agent. The basic exci...

AARON DELY，BOYONG LI，DAVID WONG